| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000018250 |
| Receipt No. | R000021121 |
| Scientific Title | Verification of healthy life expectancy stretching effect of the musculoskeletal function assessment of local residents (prospective study) |
| Date of disclosure of the study information | 2015/07/10 |
| Last modified on | 2021/01/12 (Ver. 9) |
| Basic information | ||
| Public title | Verification of healthy life expectancy stretching effect of the musculoskeletal function assessment of local residents (prospective study) | |
| Acronym | Verification of healthy life expectancy stretching effect of the musculoskeletal function assessment of local residents (prospective study) | |
| Scientific Title | Verification of healthy life expectancy stretching effect of the musculoskeletal function assessment of local residents (prospective study) | |
| Scientific Title:Acronym | Verification of healthy life expectancy stretching effect of the musculoskeletal function assessment of local residents (prospective study) | |
| Region |
|
|
| Condition | |||||
| Condition | locomotive syndrome | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | Health diagnosis, as to evaluate the health state,it is obliged to implement in schools,workplaces,local governments,consultation rate remained flat. In recent years, focusing on musculoskeletal disorders is an essential care main factor, The Japanese Orthopaedic Association has proposed the Locomotive syndrome. Therefore, for the purpose of long-term care costs increase suppression by musculoskeletal disorders, daily life functions in health diagnostic evaluation (locomotive syndrome risk test), further add to muscle function test (the lower extremity muscle strength), to perform the discovery and preventive intervention of early locomotive syndrome the thing, to verify its effectiveness. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To assess the level of the participants of motor function by which is carried out by adding locomotive syndrome risk test as daily life functional assessment and the lower limb muscle strength measurement as muscle function test and to regular health checks.
The prescription of exercise in accordance with the level of motor function, to verify the motor function improving effect. |
| Key secondary outcomes | To confirm the change of medical examination consultation rate by adding implementing the motor function evaluation to medical examination.
We consider the relevance of the medical examination data and motor function data. To compare the medical and nursing care and medical examination cost of the whole and the motor function evaluation participants. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Prevention | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Once a month, six-month exercise guidance.
6 months and measurement by the activity meter of month. Once a month, lower limb muscle strength measurement of 6 months. 6-month implementation guidance of daily life record of month. |
||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | More than 40 years old, Kanagawa Prefecture Oiso-machi townsman of national health insurance screening project participants | |||
| Key exclusion criteria | If it is painful to any of the body.
There is a disease in cardiovascular such as hypertension and blood vessels, when the musculoskeletal function assessment can not be carried out. |
|||
| Target sample size | 1500 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tokai University | ||||||
| Division name | Department of Physical Education School of Physical Education | ||||||
| Zip code | |||||||
| Address | 4-1-1 Kitakaname, Hiratsuka-shi, Kanagawa 259-1292 Japan | ||||||
| TEL | 0463-58-1211 | ||||||
| nt229356@tsc.u-tokai.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tokai University | ||||||
| Division name | Department of Physical Education School of Physical Education | ||||||
| Zip code | |||||||
| Address | 4-1-1 Kitakaname, Hiratsuka-shi, Kanagawa 259-1292 Japan | ||||||
| TEL | 0463-58-1211 | ||||||
| Homepage URL | |||||||
| nt229356@tsc.u-tokai.ac.jp | |||||||
| Sponsor | |
| Institute | Tokai University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Economy, Trade and Industry. |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | ALCARE Co., Ltd. |
| Name of secondary funder(s) | ALCARE Co., Ltd. |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000021121 |